Pharmaceutical industry news

Association between urea-to-creatinine ratio trajectories and clinical outcomes in chronic critical illness patients: a retrospective cohort study

A novel optimized surgical strategy for secondary hyperparathyroidism: clean parathyroidectomy combined with autotransplantation and its clinical analysis

Effectiveness of occupational-therapy handwriting interventions for Preschoolers (Age Group 4–6)

Assessment of Knowledge, Attitude, and Practices Regarding Prevention of Catheter-Associated Urinary Tract Infections Among Nursing Staff: A Cross-Sectional Study

Development of Stratum Corneum Lipid Liposomes for Topical Drug Delivery

Effect of Different Doses of Ondansetron on Hemodynamic Status in Patients Undergoing Elective Caesarean Section Under Spinal Anaesthesia: A Randomized Controlled Trial

Index

979 Effects of primary tumor and its ablation on the growth of metastases: a natural law

747 The laws of tumor growth

Monitorización de concentraciones séricas de abiraterona

<i>De novo ARID1A</i> Coffin-Siris syndrome with hypothyroidism and dyslipidemia: A case report and literature review

Comparative Clinical Effectiveness, Safety, and Cost-Effectiveness of Intravenous Tramadol versus Metamizole for Post-Procedural Pain Management

Integration of genetic evidence to identify approved drug targets

Virtual reality simulation for chemotherapy drug spill management training in pharmacy education: A cohort-allocated crossover quasi-experimental study in Taiwan

Effects of tablet-based augmented reality on anxiety, fear, and pain during venipuncture in children: a randomized controlled trial

Comprehensive Effects of Occupational Therapy Using Ayres Sensory Integration® in Children With ADHD: A Randomized Controlled Trial

Data from Predicting Clinical Sensitivities of &lt;i&gt;PDGFRA&lt;/i&gt; Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

Figure 4 from Predicting Clinical Sensitivities of &lt;i&gt;PDGFRA&lt;/i&gt; Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

Supp. Fig. 2 from Predicting Clinical Sensitivities of &lt;i&gt;PDGFRA&lt;/i&gt; Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

Supp. Fig. 7 from Predicting Clinical Sensitivities of &lt;i&gt;PDGFRA&lt;/i&gt; Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

Supplementary Table S2 from Predicting Clinical Sensitivities of &lt;i&gt;PDGFRA&lt;/i&gt; Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

Supplementary Table S5 from Predicting Clinical Sensitivities of &lt;i&gt;PDGFRA&lt;/i&gt; Exon 18 Mutations to Imatinib and Avapritinib to Optimize Gastrointestinal Stromal Tumor Treatment

The 69th session of the UN Commission on Narcotic Drugs: multilateral drug policy navigating fragmentation

Surface EEG to Identify Cognitive Motor Dissociation After Acute Brain Injury

Exercise testing in contemporary aortic stenosis management: translating pathophysiological insights into clinical decision-making

Effect of early skin-to-skin contact after vaginal birth on neonatal stress and day-5 bilirubin levels: a randomized trial

Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial

Analysis of the Effectiveness of Injection-Based Minimally Invasive Treatment for Piriformis Syndrome: Clinical Outcomes and Anatomical Correlates

Developmental Trajectories in Young Autistic Children Receiving Parent-Mediated Intervention Through In-Person and Telehealth Service Delivery Models: A Naturalistic, Nonrandomized Clinical Study

Cutaneous lesions with Cryptococcus-like changes in the context of ANCA vasculitis: case reports and literature review

Perinatal mental health issues in consultations regarding medication use during breastfeeding: Insights from the Japan Drug Information Institute in Pregnancy (JDIIP)

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials

Anticipated online harassment and potential chilling effects on mandatory child abuse reporting: A pilot survey of pediatricians in Japan

Optimizing integrated multienzyme‐membrane system to maximize xylo‐oligosaccharide yield and eradicate inhibitors: addressing fouling and sugar purification in pineapple residue processing

NCT07684950: Lisaftoclax Plus Pirtobrutinib in Relapsed or Refractory Mantle Cell Lymphoma After BTK-Targeted Therapy

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT07684677: Effect of Participating in a Study of Causes of Pregnancy Loss on Mental Health Outcomes: A Target Trial Emulation Using the COPL Cohort and Danish National Registries

Study type: INTERVENTIONAL. Phase: NA.

NCT07684560: Phase Ib, Randomized, Double-blind, Placebo-Controlled, Dose-Escalation Study of Alpha-0261 Tablets to Assess Safety and Tolerability in Patients With Chronic Spontaneous Urcaria (Part 1) and Food Effect in Healthy Adults (Part 2).

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT07684456: Efficacy and Safety of Utidelone Capsule and Utidelone Injection in Patients With HER-2 Negative Advanced Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07684144: Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07683377: Safety and Efficacy Analysis of Stent-assisted Coil Embolization in the Treatment of Acute Ruptured Intracranial Aneurysms in the Perioperative Period.

Study type: INTERVENTIONAL. Phase: NA.

NCT07683299: HEMO-INTEGRA: Integrated Intraoperative Hemodynamic Monitoring During Cardiac Surgery With Cardiopulmonary Bypass - A Pilot Study

Study type: OBSERVATIONAL. Phase: .

NCT07682792: Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT07601113: PG2 Breast Cancer Evaluation in Adjuvant Medicine-Survival Study

Study type: OBSERVATIONAL. Phase: .

NCT07447128: Prospective Analysis of Arteriovenous Access (AVA) Use in Continuous Renal Replacement Therapy: A Feasibility Project

Study type: INTERVENTIONAL. Phase: NA.

NCT07264114: Aquatic High-Intensity Interval Training for Parkinson's Disease

Study type: INTERVENTIONAL. Phase: NA.

NCT07174310: A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT07082998: Comparing the Efficacy of Heated Yoga and Sauna as a Treatment for Depression

Study type: INTERVENTIONAL. Phase: NA.

NCT07082049: AI-LLM Communication Aid in Prostate Cancer Care (AI-CAP）

Study type: INTERVENTIONAL. Phase: NA.

NCT06834152: Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

Study type: OBSERVATIONAL. Phase: .

NCT06663319: A Study of JNJ-89402638 for Metastatic Colorectal and Gastric Cancers

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT06627413: Safety, Tolerability, and Pharmacokinetics of Lumateperone Long-Acting Injectable Formulations in Patients With Schizophrenia or Schizoaffective Disorder

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT06441266: M-PART in Head and Neck Cancer Patients Treated With KeraStat Cream for Acute Radiation Dermatitis

Study type: INTERVENTIONAL. Phase: NA.

NCT05957276: Global Patient Registry of Inherited Retinal Diseases

Study type: OBSERVATIONAL. Phase: .

NCT05870579: [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT05138848: Time-in-bed Restriction in Older Adults With Sleep Difficulties With and Without Risk for Alzheimer's Disease

Study type: INTERVENTIONAL. Phase: EARLY_PHASE1.

NCT04722146: A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma

Study type: INTERVENTIONAL. Phase: PHASE1.

NCT04609566: Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT04084678: Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects

Study type: INTERVENTIONAL. Phase: PHASE3.

NCT03976843: Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Study type: INTERVENTIONAL. Phase: PHASE2.

NCT03854552: A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.

Study type: INTERVENTIONAL. Phase: PHASE1.